Faribourz Payvandi

1.9k total citations
19 papers, 1.6k citations indexed

About

Faribourz Payvandi is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Faribourz Payvandi has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Faribourz Payvandi's work include Multiple Myeloma Research and Treatments (5 papers), NF-κB Signaling Pathways (4 papers) and Immune Cell Function and Interaction (3 papers). Faribourz Payvandi is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), NF-κB Signaling Pathways (4 papers) and Immune Cell Function and Interaction (3 papers). Faribourz Payvandi collaborates with scholars based in United States, Switzerland and Ukraine. Faribourz Payvandi's co-authors include George W. Muller, David Stirling, Peter Schäfer, Roger S. Chen, Patricia Fitzgerald‐Bocarsly, Sheela Amrute, Austin B. Thompson, Stephen I. Rennard, Linghua Zhang and Peter S. Amenta and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.

In The Last Decade

Faribourz Payvandi

19 papers receiving 1.6k citations

Peers

Countries citing papers authored by Faribourz Payvandi

Since Specialization

Citations

This map shows the geographic impact of Faribourz Payvandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faribourz Payvandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faribourz Payvandi more than expected).

Fields of papers citing papers by Faribourz Payvandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faribourz Payvandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faribourz Payvandi. The network helps show where Faribourz Payvandi may publish in the future.

Co-authorship network of co-authors of Faribourz Payvandi

This figure shows the co-authorship network connecting the top 25 collaborators of Faribourz Payvandi. A scholar is included among the top collaborators of Faribourz Payvandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faribourz Payvandi. Faribourz Payvandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	CC-5079: A Small Molecule with MKP1, Antiangiogenic, and Antitumor Activity 2009 ·Journal of Surgical Research ·(unknown), (unknown), (unknown), Mei He, Peter Schäfer, Faribourz Payvandi, George W. Muller, David Stirling, Steven K. Libutti	15
2	The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions 2008 ·Microvascular Research ·Ling Lu, Faribourz Payvandi, Lei Wu, Linghua Zhang, Robert Hariri, Hon‐Wah Man, Roger S. Chen, George W. Muller, Christopher C.W. Hughes, David Stirling, Peter Schäfer, J. Blake Bartlett	183
3	The anticancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions 2007 ·Molecular Cancer Therapeutics ·J. Blake Bartlett, Ling Lu, Faribourz Payvandi, Lei Wu, Linghua Zhang, George W. Muller, David Stirling, Peter Schäfer	2
4	The Synthetic Compound CC-5079 Is a Potent Inhibitor of Tubulin Polymerization and Tumor Necrosis Factor-α Production with Antitumor Activity 2006 ·Cancer Research ·Linghua Zhang, Lei Wu, Heather K. Raymon, Roger S. Chen, Laura G. Corral, Michael A. Shirley, Rama Krishna Narla, (unknown), George W. Muller, David Stirling, J. Blake Bartlett, Peter Schäfer, Faribourz Payvandi	77
5	Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-θ Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-κB, OCT-1, or NF-AT 2005 ·Journal of Interferon & Cytokine Research ·Faribourz Payvandi, Lei Wu, (unknown), (unknown), Anastasia Parton, Peter Schäfer, Roger S. Chen, George W. Muller, Christopher C.W. Hughes, David Stirling	40
6	A novel PDE4 inhibitory agent with endothelial cell specific activity. 2004 ·Cancer Research ·Jennifer E. Rosen, (unknown), Mei He, (unknown), H. Richard Alexander, Faribourz Payvandi, David Stirling, Peter Schäfer, Steven K. Libutti	1
7	A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay 2004 ·Journal of Translational Medicine ·(unknown), Mark L. Kayton, (unknown), (unknown), Mei He, (unknown), Galina Baibakov, Dominique Lorang, Vladimir Knežević, Elise C. Kohn, H. Richard Alexander, David Stirling, Faribourz Payvandi, George W. Muller, Steven K. Libutti	29
8	Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-α, IL-1β, and LPS-stimulated human PBMC in a partially IL-10-dependent manner 2004 ·Cellular Immunology ·Faribourz Payvandi, Lei Wu, (unknown), Peter Schäfer, Linghua Zhang, Roger S. Chen, George W. Muller, David Stirling	65
9	Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition. 2003 ·PubMed ·Michael S. Gee, Sosina Makonnen, Khalid Al-Kofahi, Badri Roysam, Faribourz Payvandi, (unknown), George W. Muller, William M. F. Lee	14
10	Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Peter Schäfer, Anita K. Gandhi, (unknown), Roger S. Chen, Hon‐Wah Man, Paul P. M. Schnetkamp, Gregor Wolbring, (unknown), Laura G. Corral, Faribourz Payvandi, George W. Muller, David Stirling	155
11	Mechanisms of constitutive NF‐κB activation in human prostate cancer cells 2002 ·The Prostate ·Junghan Suh, Faribourz Payvandi, Leonard C. Edelstein, Peter S. Amenta, Wei‐Xing Zong, Céline Gélinas, Arnold B. Rabson	201
12	Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications 2001 ·Leukemia ·(unknown), (unknown), Yoshihito Shima, Teru Hideshima, Klaus Podar, (unknown), Boris K. Lin, Suzanne Lentzsch, Faith E. Davies, Dharminder Chauhan, R Schlossman, Paul G. Richardson, P Ralph, Lizi Wu, Faribourz Payvandi, George W. Muller, (unknown), (unknown)	450
13	Exogenous and Endogenous IL-10 Regulate IFN-α Production by Peripheral Blood Mononuclear Cells in Response to Viral Stimulation 1998 ·The Journal of Immunology ·Faribourz Payvandi, Sheela Amrute, Patricia Fitzgerald‐Bocarsly	61
14	Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. 1998 ·PubMed ·Faribourz Payvandi, Sheela Amrute, Patricia Fitzgerald‐Bocarsly	71
15	Transcription of the Murine Interleukin 5 Gene Is Regulated by Multiple Promoter Elements 1995 ·Journal of Biological Chemistry ·(unknown), Faribourz Payvandi, (unknown), Shelby P. Umland, Robert W. Egan, M. Motasim Billah	25
16	Potential Interaction of lnterleukin-4 with Endogenous Cytokines in vivo 1994 ·Pathobiology ·Lisa Sullivan, Loretta A. Bober, Michael J. Grace, (unknown), (unknown), Faribourz Payvandi, Catherine Pugliese‐Sivo, Satwant K. Narula	3
17	Interleukin-5 Modulates Eosinophil Accumulation in Allergic Guinea Pig Lung 1992 ·American Review of Respiratory Disease ·A. Gulbenkian, Robert W. Egan, Xiomara Fernandez, H. Jones, William Kreutner, T T Kung, Faribourz Payvandi, (unknown), Jackie Zurcher, Arthur S. Watnick	112
18	Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. 1990 ·PubMed ·Austin B. Thompson, (unknown), Faribourz Payvandi, Stephen I. Rennard	123
19	Monoclonal antibodies for coagglutination of Streptococcus suis type 1 1989 ·Veterinary Microbiology ·Faribourz Payvandi, Subramaniam Srikumaran, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact